Delivery Order SPE2DB20D3303-SPE2DB25FA3LU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,842.17 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This firm fixed price delivery order was competitively awarded without set-aside designation and is set for completion by August 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $1,842.17 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This firm fixed price contract, awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a competitively awarded, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,642.07 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Abilify Maintena ER 300 mg syringes. This is a firm fixed-price delivery order with an ultimate completion date of August 29, 2025. The award was made on a competitive basis with no set-aside designation, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,764.94 on July 23, 2025, for the supply of Abilify Maintena ER 300 mg vials/syringes/cartridges. This firm fixed price delivery order, with an ultimate completion date of July 24, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. The award was not designated as a set-aside contract and was competitively awarded. Performance...
- This delivery order, valued at $2,807.89, was awarded on July 18, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. The contract employs firm fixed-price pricing and is scheduled for completion by July 21, 2025. This award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. No...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Abilify Maintena ER 300 mg vials/syringes with a ceiling value of $1,382.47. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The order is scheduled for completion by August 4, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,731.25 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of 4,564,248,487 units of Abilify Maintena ER 400 mg syringes. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
- The Defense Logistics Agency awarded a $3,765.38 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Abilify Asimtufii 960 mg/3.2 mL injectable medication. This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 2, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. As a non-set-aside procurement, this delivery order was issued under open competition, reflecting the contractor's...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,714.54 for the supply of Abilify Maintena Extended-Release (ER) 400 mg syringes. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 24, 2024. The contract is a firm-fixed-price delivery order, which is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- The Defense Logistics Agency awarded a $12,158 delivery order to Amerisourcebergen Drug Corporation for 300mg doses of ABILIFY MAINTENA extended release injectable suspension. To be performed in Conshohocken, Pennsylvania under firm fixed price terms, the order runs from July 25 to July 26, 2023 to supply the pharmaceutical to an unspecified DOD program. As a major pharmaceutical distributor, Amerisourcebergen will deliver the prescribed medication to the Defense Logistics Agency without...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3LUDelivery Order
The Defense Logistics Agency awarded a $3,785.30 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This non-set-aside contract was awarded on September 9, 2025, with an ultimate completion date of September 10, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. As a prime vendor under the DLA's Pharmaceutical Prime Vendor Global Program, the company supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare operations worldwide. The Abilify Maintena delivery under this order supports the Defense Health Agency and related federal healthcare systems with this specialty psychiatric medication delivered through the established IDC framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 9/9/25 |